2.22
price up icon3.26%   0.07
after-market 시간 외 거래: 2.20 -0.02 -0.90%
loading

Allogene Therapeutics Inc (ALLO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
44.90
- 65.19 60.49 71.77
Operating Income/Loss
-44.90
- -65.19 -60.49 -71.77
Nonoperating Income/Loss
3.501
- 5.458 0.994 5.481
Income/Loss From Continuing Operations Before Tax
18.73%
-41.40
-50.94 -59.73 -59.50 -66.29
Income/Loss From Continuing Operations After Tax
18.73%
-41.40
-50.94 -59.73 -59.94 -66.29
Net Income/Loss
18.73%
-41.40
-50.94 -59.73 -59.94 -66.29
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
222.04
- 215.36 5.2919 209.19
Diluted Average Shares
222.04
- 215.36 5.2919 209.19
Basic Earnings Per Share
-0.19
- -0.28 -0.28 -0.32
Diluted Earnings Per Share
-0.19
- -0.28 -0.28 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):